The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients
Clinical trial NCT05611684 · UNKNOWN
Trial details
- NCT number
- NCT05611684
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2023-12-31
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.